Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance.

Dhadve AC, Hari K, Rekhi B, Jolly MK, De A, Ray P.

Biochim Biophys Acta Mol Basis Dis. 2020 Mar 3;1866(6):165754. doi: 10.1016/j.bbadis.2020.165754. [Epub ahead of print]

PMID:
32142859
2.

Assessment of a Day Hospital Management Program for Children With Type 1 Diabetes.

Lawson S, Redel JM, Smego A, Gulla M, Schoettker PJ, Jolly M, Mostajabi F, Hornung L.

JAMA Netw Open. 2020 Mar 2;3(3):e200347. doi: 10.1001/jamanetworkopen.2020.0347.

3.

A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells.

Tripathi S, Chakraborty P, Levine H, Jolly MK.

PLoS Comput Biol. 2020 Feb 10;16(2):e1007619. doi: 10.1371/journal.pcbi.1007619. eCollection 2020 Feb.

4.

The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition.

Tripathi S, Levine H, Jolly MK.

Annu Rev Biophys. 2020 Jan 8. doi: 10.1146/annurev-biophys-121219-081557. [Epub ahead of print]

PMID:
31913665
5.

Drivers of Satisfaction With Care for Patients With Lupus.

Jolly M, Sethi B, O'Brien C, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, Vilá LM, Moldovan I, Torralba KD, Cicognani E, Mazzoni D, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Mok CC, Clarke A, Weisman M, Wallace D.

ACR Open Rheumatol. 2019 Nov 6;1(10):649-656. doi: 10.1002/acr2.11085. eCollection 2019 Dec.

6.

Anticipating critical transitions in epithelial-hybrid-mesenchymal cell-fate determination.

Sarkar S, Sinha SK, Levine H, Jolly MK, Dutta PS.

Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 201913773. doi: 10.1073/pnas.1913773116. [Epub ahead of print]

PMID:
31843939
7.

Author Correction: Globe-LFMC, a global plant water status database for vegetation ecophysiology and wildfire applications.

Yebra M, Scortechini G, Badi A, Beget ME, Boer MM, Bradstock R, Chuvieco E, Danson FM, Dennison P, de Dios VR, Di Bella CM, Forsyth G, Frost P, Garcia M, Hamdi A, He B, Jolly M, Kraaij T, Martín MP, Mouillot F, Newnham G, Nolan RH, Pellizzaro G, Qi Y, Quan X, Riaño D, Roberts D, Sow M, Ustin S.

Sci Data. 2019 Nov 29;6(1):305. doi: 10.1038/s41597-019-0315-z.

8.

Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis.

Lourenco AR, Ban Y, Crowley MJ, Lee SB, Ramchandani D, Du W, Elemento O, George JT, Jolly MK, Levine H, Sheng J, Wong ST, Altorki NK, Gao D.

Cancer Res. 2020 Jan 15;80(2):163-169. doi: 10.1158/0008-5472.CAN-19-1427. Epub 2019 Nov 8.

9.

Pericytes enable effective angiogenesis in the presence of proinflammatory signals.

Kang TY, Bocci F, Jolly MK, Levine H, Onuchic JN, Levchenko A.

Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23551-23561. doi: 10.1073/pnas.1913373116. Epub 2019 Nov 4.

PMID:
31685607
10.

Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.

Jolly M, Annapureddy N, Arnaud L, Devilliers H.

Lupus. 2019 Dec;28(14):1628-1639. doi: 10.1177/0961203319886065. Epub 2019 Nov 1.

PMID:
31674267
11.

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer.

Thangavel H, De Angelis C, Vasaikar S, Bhat R, Jolly MK, Nagi C, Creighton CJ, Chen F, Dobrolecki LE, George JT, Kumar T, Abdulkareem NM, Mao S, Nardone A, Rimawi M, Osborne CK, Lewis MT, Levine H, Zhang B, Schiff R, Giuliano M, Trivedi MV.

J Clin Med. 2019 Oct 24;8(11). pii: E1772. doi: 10.3390/jcm8111772.

12.

Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus.

Pinto B, Jolly M, Dhooria A, Grover S, Raj JM, Devilliers H, Sharma A.

Lupus. 2019 Nov;28(13):1534-1540. doi: 10.1177/0961203319880340. Epub 2019 Oct 21.

PMID:
31635557
13.

Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.

Kalvala A, Wallet P, Yang L, Wang C, Li H, Nam A, Nathan A, Mambetsariev I, Poroyko V, Gao H, Chu P, Sattler M, Bild A, Manuel ER, Lee PP, Jolly MK, Kulkarni P, Salgia R.

J Clin Med. 2019 Oct 18;8(10). pii: E1726. doi: 10.3390/jcm8101726.

14.

Computational Modeling of Collective Cell Migration: Mechanical and Biochemical Aspects.

Yang Y, Jolly MK, Levine H.

Adv Exp Med Biol. 2019;1146:1-11. doi: 10.1007/978-3-030-17593-1_1. Review.

PMID:
31612450
15.

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.

Celià-Terrassa T, Jolly MK.

Cold Spring Harb Perspect Med. 2019 Sep 30. pii: a036905. doi: 10.1101/cshperspect.a036905. [Epub ahead of print]

PMID:
31570380
16.

Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression

Jolly MK, Celià-Terrassa T.

J Clin Med. 2019 Sep 25;8(10). pii: E1542. doi: 10.3390/jcm8101542. Review.

17.

Globe-LFMC, a global plant water status database for vegetation ecophysiology and wildfire applications.

Yebra M, Scortechini G, Badi A, Beget ME, Boer MM, Bradstock R, Chuvieco E, Danson FM, Dennison P, Resco de Dios V, Di Bella CM, Forsyth G, Frost P, Garcia M, Hamdi A, He B, Jolly M, Kraaij T, Martín MP, Mouillot F, Newnham G, Nolan RH, Pellizzaro G, Qi Y, Quan X, Riaño D, Roberts D, Sow M, Ustin S.

Sci Data. 2019 Aug 21;6(1):155. doi: 10.1038/s41597-019-0164-9. Erratum in: Sci Data. 2019 Nov 29;6(1):305.

18.

Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Towards Improvement in Fatigue.

Azizoddin DR, Jolly M, Arora S, Yelin E, Katz P.

Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24052. [Epub ahead of print]

PMID:
31421030
19.

Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary.

Nath B, Bidkar AP, Kumar V, Dalal A, Jolly MK, Ghosh SS, Biswas G.

J Clin Med. 2019 Aug 9;8(8). pii: E1194. doi: 10.3390/jcm8081194.

20.

Reducing the impact of preterm birth: Preterm birth commissioning in the United Kingdom.

Story L, Simpson NAB, David AL, Alfirevic Z Z, Bennett PR, Jolly M, Shennan AH; UK Preterm Clinical Network.

Eur J Obstet Gynecol Reprod Biol X. 2019 Apr 21;3:100018. doi: 10.1016/j.eurox.2019.100018. eCollection 2019 Jul. Review.

21.

Phenotypic heterogeneity in circulating tumor cells and its prognostic value in metastasis and overall survival.

Saxena K, Subbalakshmi AR, Jolly MK.

EBioMedicine. 2019 Aug;46:4-5. doi: 10.1016/j.ebiom.2019.07.074. Epub 2019 Aug 6. No abstract available.

22.

Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression.

Saxena K, Jolly MK.

Biomolecules. 2019 Aug 3;9(8). pii: E339. doi: 10.3390/biom9080339. Review.

23.

A possible role for epigenetic feedback regulation in the dynamics of the epithelial-mesenchymal transition (EMT).

Jia W, Deshmukh A, Mani SA, Jolly MK, Levine H.

Phys Biol. 2019 Sep 6;16(6):066004. doi: 10.1088/1478-3975/ab34df.

24.

NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.

Bocci F, Tripathi SC, Vilchez Mercedes SA, George JT, Casabar JP, Wong PK, Hanash SM, Levine H, Onuchic JN, Jolly MK.

Integr Biol (Camb). 2019 Jun 1;11(6):251-263. doi: 10.1093/intbio/zyz021.

25.

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.

Mambetsariev I, Mirzapoiazova T, Lennon F, Jolly MK, Li H, Nasser MW, Vora L, Kulkarni P, Batra SK, Salgia R.

J Clin Med. 2019 Jul 16;8(7). pii: E1038. doi: 10.3390/jcm8071038.

26.

Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines.

Varankar SS, More M, Abraham A, Pansare K, Kumar B, Narayanan NJ, Jolly MK, Mali AM, Bapat SA.

Carcinogenesis. 2019 Jun 25. pii: bgz119. doi: 10.1093/carcin/bgz119. [Epub ahead of print]

PMID:
31241128
27.

Seed targeted RNAi-mediated silencing of GmMIPS1 limits phytate accumulation and improves mineral bioavailability in soybean.

Kumar A, Kumar V, Krishnan V, Hada A, Marathe A, C P, Jolly M, Sachdev A.

Sci Rep. 2019 May 23;9(1):7744. doi: 10.1038/s41598-019-44255-7.

28.

Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response.

Jia D, Li X, Bocci F, Tripathi S, Deng Y, Jolly MK, Onuchic JN, Levine H.

J Clin Med. 2019 May 22;8(5). pii: E725. doi: 10.3390/jcm8050725. Review.

29.

Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer.

Jolly MK, Preca BT, Tripathi SC, Jia D, George JT, Hanash SM, Brabletz T, Stemmler MP, Maurer J, Levine H.

APL Bioeng. 2018 Aug 22;2(3):031908. doi: 10.1063/1.5024874. eCollection 2018 Sep.

30.

E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms.

Jolly MK, Ware KE, Xu S, Gilja S, Shetler S, Yang Y, Wang X, Austin RG, Runyambo D, Hish AJ, Bartholf DeWitt S, George JT, Kreulen RT, Boss MK, Lazarides AL, Kerr DL, Gerber DG, Sivaraj D, Armstrong AJ, Dewhirst MW, Eward WC, Levine H, Somarelli JA.

Mol Cancer Res. 2019 Jun;17(6):1391-1402. doi: 10.1158/1541-7786.MCR-18-0763. Epub 2019 Mar 12.

31.

Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.

Tóth DM, Ocskó T, Balog A, Markovics A, Mikecz K, Kovács L, Jolly M, Bukiej AA, Ruthberg AD, Vida A, Block JA, Glant TT, Rauch TA.

Arthritis Rheumatol. 2019 Aug;71(8):1265-1275. doi: 10.1002/art.40877. Epub 2019 Jun 18.

PMID:
30835944
32.

Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level.

Lin X, Kulkarni P, Bocci F, Schafer NP, Roy S, Tsai MY, He Y, Chen Y, Rajagopalan K, Mooney SM, Zeng Y, Weninger K, Grishaev A, Onuchic JN, Levine H, Wolynes PG, Salgia R, Rangarajan G, Uversky V, Orban J, Jolly MK.

Biomolecules. 2019 Feb 22;9(2). pii: E77. doi: 10.3390/biom9020077.

33.

Quantification of myocardial deformation by deformable registration-based analysis of cine MRI: validation with tagged CMR.

Lamacie MM, Houbois CP, Greiser A, Jolly MP, Thavendiranathan P, Wintersperger BJ.

Eur Radiol. 2019 Jul;29(7):3658-3668. doi: 10.1007/s00330-019-06019-9. Epub 2019 Feb 15.

PMID:
30770973
34.

An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance.

Xu S, Ware KE, Ding Y, Kim SY, Sheth MU, Rao S, Chan W, Armstrong AJ, Eward WC, Jolly MK, Somarelli JA.

J Clin Med. 2019 Feb 7;8(2). pii: E205. doi: 10.3390/jcm8020205.

35.

Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer.

Shinde A, Hardy SD, Kim D, Akhand SS, Jolly MK, Wang WH, Anderson JC, Khodadadi RB, Brown WS, George JT, Liu S, Wan J, Levine H, Willey CD, Krusemark CJ, Geahlen RL, Wendt MK.

Cancer Res. 2019 Apr 15;79(8):1831-1843. doi: 10.1158/0008-5472.CAN-18-2636. Epub 2019 Feb 7.

PMID:
30733195
36.

Computational Modeling of the Crosstalk Between Macrophage Polarization and Tumor Cell Plasticity in the Tumor Microenvironment.

Li X, Jolly MK, George JT, Pienta KJ, Levine H.

Front Oncol. 2019 Jan 23;9:10. doi: 10.3389/fonc.2019.00010. eCollection 2019.

37.

Quantitative Characteristic of ncRNA Regulation in Gene Regulatory Networks.

Bocci F, Jolly MK, Levine H, Onuchic JN.

Methods Mol Biol. 2019;1912:341-366. doi: 10.1007/978-1-4939-8982-9_14.

PMID:
30635901
38.

The DNA walk and its demonstration of deterministic chaos-relevance to genomic alterations in lung cancer.

Hewelt B, Li H, Jolly MK, Kulkarni P, Mambetsariev I, Salgia R.

Bioinformatics. 2019 Aug 15;35(16):2738-2748. doi: 10.1093/bioinformatics/bty1021.

39.

Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.

Bocci F, Gearhart-Serna L, Boareto M, Ribeiro M, Ben-Jacob E, Devi GR, Levine H, Onuchic JN, Jolly MK.

Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):148-157. doi: 10.1073/pnas.1815345116. Epub 2018 Dec 26.

40.

Fatigue in systemic lupus: the role of disease activity and its correlates.

Azizoddin DR, Gandhi N, Weinberg S, Sengupta M, Nicassio PM, Jolly M.

Lupus. 2019 Feb;28(2):163-173. doi: 10.1177/0961203318817826. Epub 2018 Dec 22.

PMID:
30580659
41.

Testing the gene expression classification of the EMT spectrum.

Jia D, George JT, Tripathi SC, Kundnani DL, Lu M, Hanash SM, Onuchic JN, Jolly MK, Levine H.

Phys Biol. 2019 Jan 18;16(2):025002. doi: 10.1088/1478-3975/aaf8d4.

PMID:
30557866
42.

Stability and mean residence times for hybrid epithelial/mesenchymal phenotype.

Biswas K, Jolly MK, Ghosh A.

Phys Biol. 2019 Jan 29;16(2):025003. doi: 10.1088/1478-3975/aaf7b7.

PMID:
30537698
43.

Challenges to Practicing Rheumatology in an Academic Center.

Hassan S, Smith MM, Block JA, Jolly M.

Rheum Dis Clin North Am. 2019 Feb;45(1):27-37. doi: 10.1016/j.rdc.2018.09.003. Review.

PMID:
30447744
44.

Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Eapen MS, Hansbro PM, Larsson-Callerfelt AK, Jolly MK, Myers S, Sharma P, Jones B, Rahman MA, Markos J, Chia C, Larby J, Haug G, Hardikar A, Weber HC, Mabeza G, Cavalheri V, Khor YH, McDonald CF, Sohal SS.

Drugs. 2018 Nov;78(16):1717-1740. doi: 10.1007/s40265-018-1001-8. Review.

PMID:
30392114
45.

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.

Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H.

Pharmacol Ther. 2019 Feb;194:161-184. doi: 10.1016/j.pharmthera.2018.09.007. Epub 2018 Sep 28. Review.

PMID:
30268772
46.

Mitral annular velocity measurement with cardiac magnetic resonance imaging using a novel annular tracking algorithm: Validation against echocardiography.

Thavendiranathan P, Guetter C, da Silveira JS, Lu X, Scandling D, Xue H, Jolly MP, Raman SV, Simonetti OP.

Magn Reson Imaging. 2019 Jan;55:72-80. doi: 10.1016/j.mri.2018.08.018. Epub 2018 Aug 31.

47.

Patient-Reported Outcomes Predict Mortality in Lupus.

Azizoddin DR, Jolly M, Arora S, Yelin E, Katz P.

Arthritis Care Res (Hoboken). 2019 Aug;71(8):1028-1035. doi: 10.1002/acr.23734. Epub 2019 Jul 13.

PMID:
30144293
48.

Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus.

Bhattacharya J, Pappas K, Toz B, Aranow C, Mackay M, Gregersen PK, Doumbo O, Traore AK, Lesser ML, McMahon M, Utset T, Silverman E, Levy D, McCune WJ, Jolly M, Wallace D, Weisman M, Romero-Diaz J, Diamond B.

Mol Med. 2018 Jun 1;24(1):24. doi: 10.1186/s10020-018-0019-4.

49.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 2.

PMID:
30079582
50.

A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.

Bocci F, Jolly MK, George JT, Levine H, Onuchic JN.

Oncotarget. 2018 Jul 6;9(52):29906-29920. doi: 10.18632/oncotarget.25692. eCollection 2018 Jul 6.

Supplemental Content

Support Center